Home Cart Sign in  
Chemical Structure| 1032349-77-1 Chemical Structure| 1032349-77-1

Structure of MK-2206
CAS No.: 1032349-77-1

Chemical Structure| 1032349-77-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MK-2206 is an orally active, highly potent and selective allosteric Akt inhibitor, with IC50s of 8, 12, and 65 nM for Akt1, Akt2, and Akt3, respectively. Many breast cancer cell lines, and PIK3CA-mutant and cell lines with PTEN loss are sensitive to MK-2206. Anticancer activities[1][2].

Synonyms: MK-2206

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Alouche, Nagham ; Bonaud, Amelie ; Rondeau, Vincent ; Hussein-Agha, Rim ; Nguyen, Julie ; Bisio, Valeria , et al.

Abstract: The extrafollicular immune response is essential to generate a rapid but transient wave of protective antibodies during infection. Despite its importance, the mol. mechanisms controlling this first response are poorly understood. Here, we demonstrate that enhanced Cxcr4 signaling caused by defective receptor desensitization leads to exacerbated extrafollicular B-cell response. Using a mouse model bearing a gain-of-function mutation of Cxcr4 described in 2 human hematol. disorders, warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome and Waldenstrom macroglobulinemia, we demonstrated that mutant B cells exhibited enhanced mechanistic target of rapamycin signaling, cycled more, and differentiated more potently into plasma cells than wild-type B cells after Toll-like receptor (TLR) stimulation. Moreover, Cxcr4 gain of function promoted enhanced homing and persistence of immature plasma cells in the bone marrow, a phenomenon recapitulated in WHIM syndrome patient samples. This translated in increased and more sustained production of antibodies after T-independent immunization in Cxcr4 mutant mice. Thus, our results establish that fine-tuning of Cxcr4 signaling is essential to limit the strength and length of the extrafollicular immune response.

Keywords: cxcr4 receptors ; receptor desensitization ; hematological diseases ; mice ; immune response ; b-lymphocytes ; mutation

Purchased from AmBeed:

Alternative Products

Product Details of MK-2206

CAS No. :1032349-77-1
Formula : C25H22ClN5O
M.W : 443.93
SMILES Code : O=C1NN=C2C3=C(N=C(C4=CC=C(C5(N)CCC5)C=C4)C(C6=CC=CC=C6)=C3)C=CN21.[H]Cl
Synonyms :
MK-2206

Safety of MK-2206

Related Pathways of MK-2206

PI3K-AKT

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.25mL

0.45mL

0.23mL

11.26mL

2.25mL

1.13mL

22.53mL

4.51mL

2.25mL

 

Historical Records

Categories